Regulus Therapeutics Inc. buy SVB Leerink LLC
Start price
18.03.24
/
50%
€2.10
Target price
18.03.25
€5.51
Performance (%)
-40.48%
End price
19.03.25
€1.25
Summary
This prediction ended on 19.03.25 with a price of €1.25. Massive losses of -40.48% were the result for the BUY prediction by SVB_Leerink_LLC. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten